| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 104 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 102 |
| 2 | TACROLIMUS OINTMENT 0.1% | 102 |
| 3 | CYCLOSPORINE | 92 |
| 4 | MYCOPHENOLATE MOFETIL | 86 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 86 |
| 6 | METHOTREXATE SODIUM | 74 |
| 7 | METHOTREXATE | 69 |
| 8 | FLUDARABINE PHOSPHATE | 61 |
| 9 | PREDNISONE | 59 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELUMOSUDIL | 10 | 0.0030 |
| 1 | SIROLIMUS | 29 | 0.0021 |
| 2 | THIOTEPA | 19 | 0.0019 |
| 3 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 2 | 0.0019 |
| 4 | BUSULFAN | 30 | 0.0019 |
| 5 | FLUDARABINE PHOSPHATE | 61 | 0.0015 |
| 6 | GILTERITINIB | 6 | 0.0015 |
| 7 | TREOSULFAN | 4 | 0.0014 |
| 8 | ASCIMINIB | 4 | 0.0011 |
| 9 | PENTOSTATIN | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 129 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 92 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 69 |
| 3 | Kinase Inhibitor [EPC] | 69 |
| 4 | Alkylating Drug [EPC] | 67 |
| 5 | Janus Kinase Inhibitor [EPC] | 45 |
| 6 | mTOR Inhibitor Immunosuppressant [EPC] | 29 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 25 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 22 |
| 9 | Thalidomide Analog [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 3 | 0.0009 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 92 | 0.0007 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Antimalarial [EPC] | 4 | 0.0004 |
| 4 | Antiprotozoal [EPC] | 4 | 0.0004 |
| 5 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | Janus Kinase Inhibitor [EPC] | 45 | 0.0003 |
| 7 | Alkylating Drug [EPC] | 67 | 0.0003 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 5 | 0.0003 |
| 9 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |